Episode
FDA Revises Trial Requirements for Drug and Medical Product Approval
- Podcast
- Neurology® Podcast
- Published
- Mar 31, 2026
- Duration seconds
- 882
- Processing state
not_requested- Canonical source
- https://neurology.libsyn.com/fda-revises-trial-requirements-for-drug-and-medical-product-approval
Actions
POST https://stenobird.com/v1/public/podcasts/neurology-podcast-635512/episodes/fda-revises-trial-requirements-for-drug-and-medical-product-approval/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/neurology-podcast-635512/fda-revises-trial-requirements-for-drug-and-medical-product-approval.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr. Justin Abbatemarco talks with Lizzy Lawrence about the FDA's shift toward single-trial drug approvals and its implications for neurology, rare diseases, and broader effects on drug approval standards and healthcare access. Read the related article on STAT News . Disclosures can be found at Neurology.org .